Amgen Inc (NASDAQ:AMGN)

283.79
Delayed Data
As of Nov 25
 +0.39 / +0.14%
Today’s Change
198.64
Today|||52-Week Range
296.67
+26.15%
Year-to-Date
Mirati's (MRTX) Stock Rallies 11% on Buyout Speculations
Nov 24 / Zacks.com - Paid Partner Content
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
Nov 21 / Zacks.com - Paid Partner Content
Is This Biotech Stock a Buy for Under $3?
Nov 23 / StockNews.com - Paid Partner Content
Take the Zacks Approach to Beat the Market: Axon, Rollins, Starbucks in Focus
Nov 21 / Zacks.com - Paid Partner Content
Buy this Medical Sector Pioneer Stock
Nov 22 / Zacks.com - Paid Partner Content
CytomX (CTMX) Stock Surges on Oncology Deal With Regeneron
Nov 18 / Zacks.com - Paid Partner Content
Should You Invest in the VanEck Biotech ETF (BBH)?
Nov 22 / Zacks.com - Paid Partner Content
2 Stocks to Buy Whether or Not a Recession Is Coming
Nov 18 / MotleyFool.com - Paid Partner Content
2 Biotech Stocks to Buy in November and 1 to Sell
Nov 21 / StockNews.com - Paid Partner Content
Key Factors Driving Amgen's (AMGN) Outperformance This Year
Nov 17 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close283.40
Today’s open282.98
Day’s range281.48 - 285.62
Volume66,805
Average volume (3 months)2,690,784
Market cap$151.4B
Data as of 1:00pm ET, 11/25/2022

Growth & Valuation

Earnings growth (last year)-16.60%
Earnings growth (this year)+3.40%
Earnings growth (next 5 years)+9.18%
Revenue growth (last year)+2.94%
P/E ratio22.8
Price/Sales4.96
Price/Book23.64

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences+0.84+0.98%
----
MRNAModerna Inc-0.01-0.01%
BIIBBiogen+1.73+0.57%
Data as of 2:58pm ET, 11/25/2022

Financials

Next reporting dateFebruary 2, 2023
EPS forecast (this quarter)$4.09
Annual revenue (last year)$26.0B
Annual profit (last year)$5.9B
Net profit margin22.68%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Thousand Oaks, California

Forecasts